HQY delivered exceptional financial performance with revenue surging 304% while significantly expanding their HSA customer base and assets under management.
This represents a dramatic acceleration in HQY's business growth, with revenue more than quadrupling while maintaining strong profitability metrics. The company's strategic expansion beyond basic healthcare savings into "investing decisions" and marketplace solutions appears to be driving substantial customer acquisition and revenue per account growth.
HQY demonstrated explosive growth across all key metrics, with revenue jumping 304% to $229.5M and net income more than doubling to $215.2M, while operating cash flow increased a solid 34.5% to $457.1M. The company significantly increased share buybacks to $299.3M, reflecting strong cash generation and management confidence, while gross profit grew a more modest 17.5% suggesting improved operational leverage. The massive revenue growth combined with strong profitability and cash flow generation signals HQY has successfully scaled its healthcare technology platform and captured significant market share in the expanding HSA market.
Strong top-line growth of 304.2% — accelerating demand or successful expansion into new markets.
Share repurchases increased 146.3% — management returning capital, signals confidence in intrinsic value.
Net income grew 122.5% — bottom-line growth signals improving overall business health.
Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.
Inventory drawn down 63.7% — strong sell-through or deliberate destocking; watch for supply constraints.
Operating cash flow surged 34.5% — exceptional cash generation, highest quality earnings signal.
Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →